Haemonetics Corp. (hae 0 03/01/26)

13F holders, Q4 2025 (December 31)
11holders +1
3new positions
2sold out
$0.99avg. 13F price*

At the end of Q4 2025, 11 institutions reported holding Haemonetics Corp. (hae 0 03/01/26) in their 13F filings, up 1 from Q3 2025. 3 opened new positions and 2 sold out. The largest holders were Angelo Gordon & Co., L.P. ($5.9M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($3.0M) and Sei Investments Co. ($331K).

Company
Haemonetics Corp. (hae 0 03/01/26)
CUSIP
405024AB6
Latest filing quarter
Q4 2025

History

Number of 13F holders

051015 Q1 2024: 7Q1 2024Q2 2024: 6Q2 2024Q3 2024: 10Q3 2024Q4 2024: 9Q4 2024Q1 2025: 8Q1 2025Q2 2025: 9Q2 2025Q3 2025: 10Q3 2025Q4 2025: 11Q4 2025

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions3$34K
Exits2$51K

All 13F filers, Q3 2025 → Q4 2025: 34,000 shares bought and 52,000 shares sold, net −18,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 11 holders

Angelo Gordon & Co., L.P. 0.70% No change 6,000,000 $5.9M
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.00% No change 3,000,000 $3.0M
Sei Investments Co. 0.00% No change 335,000 $331K
Oppenheimer Asset Management Inc. 0.00% No change 192,000 $190K
Financial Consulate, Inc. 0.01% No change 68,000 $67K
Stephens Inc. 0.00% No change 59,000 $58K
Wealthspire Advisors, LLC 0.00% No change 28,000 $28K
Commonwealth Equity Services, LLC 0.00% No change 20,000 $20K
MML Investors Services, LLC 0.00% New 19,000 $19K
Tred Avon Family Wealth, LLC 0.00% New 10,000 $10K
CoreCap Advisors, LLC 0.00% New 5,000 $5K

"% of holder's portfolio" is HAEMONETICS CORP (HAE 0 03/01/26)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 0 03/01/26) the manager owns.